Orchestra BioMed
OBIO
OBIO
47 hedge funds and large institutions have $116M invested in Orchestra BioMed in 2024 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.41% more ownership
Funds ownership: 37.31% → 39.72% (+2.4%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
47
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$3.45M | |
| 2 | +$1.04M | |
| 3 | +$947K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$494K |
| 5 |
Bank of New York Mellon
New York
|
+$309K |
Top Sellers
| 1 | -$272K | |
| 2 | -$150K | |
| 3 | -$117K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$61.7K |
| 5 |
AIG
American International Group
New York
|
-$37.8K |